News & Updates

Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants

20 Oct 2023 by

A Beta variant-containing vaccine conferred protection against different SARS-CoV-2 variants, with an acceptable safety profile in adults <60 years, a phase III trial has shown.

Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants

20 Oct 2023

Bivalent mRNA vaccine confers protection against SARS-COV-2 infection in young children

18 Oct 2023 by

Bivalent COVID-19 vaccine conferred protection against SARS-COV-2 infection among children and adolescents aged 5–11 years, according to a recent study presented at IDWeek 2023.

Bivalent mRNA vaccine confers protection against SARS-COV-2 infection in young children

18 Oct 2023

Chikungunya vaccine induces robust immune response in adolescents, adults

17 Oct 2023 by

The use of chikungunya virus-like particle vaccine (CHIKV VLP) results in significantly higher seroresponse rate* and superior immunogenicity in adolescents and adults compared with placebo, according to two pivotal phase III trials presented at IDWeek 2023.

Chikungunya vaccine induces robust immune response in adolescents, adults

17 Oct 2023

HIV treatment discontinuation less frequent with B/F/TAF than DTG/3TC

16 Oct 2023 by

In a real-world cohort, virologically suppressed HIV patients who switched from a prior regimen to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) were less likely to discontinue their regimen than those who switched to dolutegravir/lamivudine (DTG/3TC).

HIV treatment discontinuation less frequent with B/F/TAF than DTG/3TC

16 Oct 2023

RSV vaccine effective across two seasons

16 Oct 2023 by

The respiratory syncytial virus (RSV) vaccine by GSK demonstrated sustained effectiveness of about 67 percent among adults 60 years or older across two full RSV seasons in a phase III study, says an infectious disease expert who reported findings at IDWeek 2023.

RSV vaccine effective across two seasons

16 Oct 2023

COVID-19 vaccination possibly linked to menstrual abnormalities

14 Oct 2023

A high incidence of menstrual disorders among women aged ≤54 years has been noted following COVID-19 vaccination, reveals a Netherlands study. Analysis of spontaneous reports supports this observation.

COVID-19 vaccination possibly linked to menstrual abnormalities

14 Oct 2023

Ambient PM2.5 linked to TB reactivation in the elderly

13 Oct 2023 by

A spatio-temporal analysis by researchers from The Chinese University of Hong Kong finds significant associations between high ambient particulate matter (PM)_2.5 concentration and increased rates of pulmonary tuberculosis (TB) among the elderly.

Ambient PM2.5 linked to TB reactivation in the elderly

13 Oct 2023

PPI use poses risk of serious infections in kids

12 Oct 2023

Use of proton pump inhibitor (PPI) appears to contribute to an increased risk of serious infections in children, as reported in a study.

PPI use poses risk of serious infections in kids

12 Oct 2023

Pott’s puffy tumor not uncommon in teens with prolonged headache

10 Oct 2023

A recent study recommends having a high index of suspicion for Pott’s puffy tumour (PPT), a rare complication of frontal sinusitis, among adolescents who present with prolonged headache or frontal swelling.

Pott’s puffy tumor not uncommon in teens with prolonged headache

10 Oct 2023

Original New Drug Application Approvals by US FDA (15-30 September 2023)

10 Oct 2023

New drug applications approved by US FDA as of 15-30 September 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (15-30 September 2023)

10 Oct 2023

News & Updates

Filter by Specialty:

Specialty:

Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants

Beta strain-containing bivalent vaccine protects against various SARS-CoV-2 variants

Bivalent mRNA vaccine confers protection against SARS-COV-2 infection in young children

Bivalent mRNA vaccine confers protection against SARS-COV-2 infection in young children

Chikungunya vaccine induces robust immune response in adolescents, adults

Chikungunya vaccine induces robust immune response in adolescents, adults

HIV treatment discontinuation less frequent with B/F/TAF than DTG/3TC

HIV treatment discontinuation less frequent with B/F/TAF than DTG/3TC

RSV vaccine effective across two seasons

RSV vaccine effective across two seasons

COVID-19 vaccination possibly linked to menstrual abnormalities

COVID-19 vaccination possibly linked to menstrual abnormalities

Ambient PM2.5 linked to TB reactivation in the elderly

Ambient PM2.5 linked to TB reactivation in the elderly

PPI use poses risk of serious infections in kids

PPI use poses risk of serious infections in kids

Pott’s puffy tumor not uncommon in teens with prolonged headache

Pott’s puffy tumor not uncommon in teens with prolonged headache

Original New Drug Application Approvals by US FDA (15-30 September 2023)

Original New Drug Application Approvals by US FDA (15-30 September 2023)